Mergers & Acquisitions

  • August 10, 2026

    Jazz Pharma Buying Actio In Up To $1.32B Epilepsy Push

    Dublin-based Jazz Pharmaceuticals PLC said Monday it will pay up to $1.32 billion for privately held Actio Biosciences, with Hogan Lovells Cadwalader advising Jazz and Cooley LLP guiding Actio. 

  • August 10, 2026

    3 Firms Guide Teledyne's $1.1B Varex Imaging Deal

    Teledyne Technologies Inc. said Monday it has agreed to purchase Varex Imaging Corp. in a deal valued at about $1.1 billion, with Latham & Watkins LLP and McGuireWoods LLP advising Teledyne and Orrick Herrington & Sutcliffe LLP representing Varex.

  • August 07, 2026

    DOJ, Tenn. Require Plant Sales For CRH's $134M Asphalt Deal

    The U.S. Department of Justice and Tennessee state enforcers reached an agreement with CRH plc Friday, allowing the building material supplier to move ahead with its planned $133.9 million purchase of Standard Construction, conditioned on the sale of two asphalt plants.

  • August 07, 2026

    WWE's $147M Merger Settlement Held Up By Defense Dispute

    World Wrestling Entertainment shareholders are asking a Delaware court to force Vince McMahon and other WWE board directors to sign off on a $147 million deal that will end a lawsuit over the company's 2023 merger with UFC parent Endeavor, with parties indicating that a dispute has opened up among the defendants over insurance coverage.

  • August 07, 2026

    Shippers, Rivals Want UP, Norfolk Southern Deal Rejected

    Rival railroads and several associations of major freight customers are urging the Surface Transportation Board to reject the planned $85 billion merger between Union Pacific Corp. and Norfolk Southern Corp., saying the rail giants have failed to show the deal is in the public interest.

  • August 07, 2026

    REITs Must Face Shareholders' Suit Over Delayed Liquidation

    A New Jersey federal judge refused to let a group of real estate investment trusts and other parties escape a proposed class action accusing them of tricking shareholders into approving amended legacy charters that delayed the liquidation process, which prevented shareholders from cashing out.

  • August 07, 2026

    KKR Buying Medicover's India Business In $1.4B Deal

    Global investment firm KKR has agreed to acquire Medicover Hospitals India, Swedish healthcare provider Medicover AB's Indian hospital operations business, in a transaction that values the platform at about €1.2 billion ($1.4 billion).

  • August 07, 2026

    Taxation With Representation: Slaughter And May, Covington

    In this week's Taxation With Representation, U.K. real estate investment trust Segro's board agrees to a share offer from U.S. rival Prologis with a partial cash alternative, Curium acquires fellow radiopharmaceutical company Lantheus Holdings Inc., and investment firm KKR buys medical device company Integer Holdings Corp.

  • August 07, 2026

    18 State AGs Urge Feds To Block OppFi's BNC Bank Acquisition

    A coalition of 18 state attorneys general led by Illinois Attorney General Kwame Raoul urged federal regulators to block Opportunity Financial's proposed acquisition of BNC National Bank, saying the deal would allow the online lender to sidestep state interest rate limits and expand its high-cost lending nationwide.

  • August 07, 2026

    Trump Picks FCC Lawyer As Agency's 3rd Republican

    President Donald Trump on Friday picked Danielle Thumann Severs, an in-house lawyer at the Federal Communications Commission, to fill an open seat on the regulatory board.

  • August 07, 2026

    3 Firms Advise On $2.15B Nielsen, DoubleVerify Deal

    Nielsen Holdings has agreed to acquire DoubleVerify in an all-cash transaction with an enterprise value of approximately $2.15 billion, in a deal steered by three law firms that will also see Providence Equity Partners exit its investment in DoubleVerify.

  • August 07, 2026

    Dream Finders Inks $2.2B Beazer Deal After Months Of Pursuit

    Dream Finders Homes said Friday it has agreed to purchase Beazer Homes USA in a $2.2 billion deal after pursuing the homebuilder for months, with Foley & Lardner LLP and King & Spalding LLP advising, respectively. 

  • August 06, 2026

    Nexstar Execs Can't Be On Tegna Board, Judge Clarifies

    A California federal judge clarified Thursday that Nexstar executives and other affiliated personnel cannot serve as Tegna directors under a temporary injunction blocking the broadcast giants' $6.2 billion merger, while admonishing the companies for not disclosing the appointment of three Nexstar officials to Tegna's board.

  • August 06, 2026

    3 Firms Guide Reusable Spacecraft Maker's $380M SPAC Deal

    Orbital spacecraft maker Blackstar Orbital Technologies Corp. on Thursday unveiled plans to go public by merging with special purpose acquisition company Pono Capital Four Inc. in a deal that values it at $380 million and was built by three law firms.

  • August 06, 2026

    Paramount Gets Private Warner Deal Challenge Tossed

    A California federal court has dismissed a case from consumers looking to undo Paramount's completed merger with Skydance and block its planned purchase of Warner Bros. Discovery, finding they failed to show any concrete harm from the deals.

  • August 06, 2026

    Tarsus Bets Up To $800M On Alkeus In Retina Therapy Push

    Tarsus Pharmaceuticals Inc. said Thursday it has agreed to acquire privately held Alkeus Pharmaceuticals Inc. for up to approximately $800 million, expanding the Irvine, California-based eye care company's pipeline into retinal disease with an experimental treatment for Stargardt disease.

  • August 06, 2026

    FCC Lifts 39% Broadcast Ownership Cap In Controversial Vote

    The Federal Communications Commission voted 2-1 to eliminate the 39% national cap on broadcast TV audience share Thursday, with Republicans saying the change will help local stations survive and dismissing claims that the agency was exceeding its legal powers.

  • August 06, 2026

    Akin Brings On 2 Mayer Brown Energy Attys In Chicago

    Two former Mayer Brown LLP energy and infrastructure attorneys have moved to Akin Gump Strauss Hauer & Feld LLP's fast-growing Chicago office, the firm announced Wednesday.

  • August 06, 2026

    Veteran M&A Atty Named A&O Shearman's LA Office Head

    Allen Overy Shearman Sterling announced that an experienced mergers and acquisitions and private equity attorney from Sidley Austin LLP has joined the firm in Los Angeles, where she has also been named office managing partner.

  • August 06, 2026

    Shein Eyes $40B Valuation Via Hong Kong IPO, More Rumors

    Fast-fashion company Shein is seeking a $40 billion valuation through its Hong Kong initial public offering, betting platform Polymarket is eyeing a new funding round that could value it at $20 billion and Cencora's MWI Animal Health merger with Covetrus faces regulatory scrutiny.

  • August 06, 2026

    Telecom Co. Denied Coverage For $27M 'Bump-Up' Settlement

    Insurers do not owe coverage to a telecom company for a $27 million settlement with shareholders who said they were shorted in an acquisition, the Delaware Superior Court said, finding the settlement was a "bump-up" in shareholder consideration that was excluded under the company's directors and officers coverage.

  • August 06, 2026

    EasyJet Agrees To $7.7B Apollo Buyout, Castlelake Bows Out

    Apollo Global Management has agreed to acquire easyJet for approximately £5.7 billion ($7.7 billion), the companies said Thursday, ending a bidding contest with private equity firm Castlelake for the U.K. budget airline.

  • August 06, 2026

    Suit Against Ex-Lumio Execs Will Stay In Delaware

    A Delaware bankruptcy judge Thursday denied a request by former executives of solar panel provider Lumio Holdings to transfer a suit against them by the company's liquidating trustee to a Utah court.

  • August 06, 2026

    Travers Smith Guides Peel Group's £583M Offer For Harworth

    British real estate investor Peel Group said Thursday it has made a cash offer to take full control of Harworth in a deal that values the property developer at £583 million ($784 million).

  • August 05, 2026

    Panel Rejects BMS Investor's Bid To 'Camouflage A Wolf'

    A New Jersey state appeals court said an investor's amended complaint over Bristol-Myers Squibb Co.'s $74 billion acquisition of Celgene Corp. was a wolf camouflaged in sheep's clothing, finding that the investor's claims of disclosure requirement shortfalls sounded more in fraud than negligence and failed to satisfy the heightened pleading standard required.

Expert Analysis

  • Navigating OFAC's 50% Rule For Cross-Border Exec Mobility

    Author Photo

    A recent Office of Foreign Assets Control guide signals that its 50% ownership rule can determine not only sanctions compliance but also whether a company can sponsor multinational executives for immigration, highlighting an often overlooked interaction between sanctions and immigration law, says Xuan Zhang at Reid & Wise.

  • What PE Practitioners Need To Know About New Del. ABC Act

    Author Photo

    Delaware's new Assignment for the Benefit of Creditors statute represents a structural shift in how companies backed by private equity can be wound down and provides a more streamlined tool for managing sponsor liability without the public visibility of a bankruptcy proceeding, says Evelyn Meltzer at Troutman Pepper.

  • Series

    Being A Magician Makes Me A Better Lawyer

    Author Photo

    The skills I've developed as a lifelong magician have translated directly into tangible benefits in the courtroom because performing magic and trying cases both live at the intersection of psychology, storytelling, timing and disciplined rehearsal, says Mark Dombroff at Fox Rothschild.

  • Illinois Audit Law Will Make AI Clauses Actually Enforceable

    Author Photo

    A law recently enacted in Illinois creates a first-in-the-nation requirement for artificial intelligence developers to undergo annual audits, providing objective standards that can be incorporated into private contracts and addressing the problem of defining responsible AI use, says William Tanenbaum at Moses & Singer.

  • Fiduciary Duty Risks In Continuation Vehicle Transactions

    Author Photo

    Continuation vehicle transactions have become prominent in private equity, but conflicts may arise due to transaction structures and implicate fiduciary duties, with a recent Delaware case highlighting several procedural considerations for sponsors, say attorneys at Debevoise.

  • A New Regulatory Environment For PE In Calif. Healthcare

    Author Photo

    The California Office of Health Care Affordability's proposed revisions to its cost and market impact review regulations, amid broader state scrutiny of private equity-backed healthcare arrangements, represent a qualitative shift in California's regulatory posture toward institutional healthcare investment, say attorneys at Ropes & Gray.

  • CFIUS' Mandate Misses Foreign Risk In Project Subcontracts

    Author Photo

    Recent calls for the Committee on Foreign Investment in the United States to review equity transactions like the Paramount Skydance-Warner Bros. deal miss a consequential oversight gap — CFIUS' inability to review the subcontracting layer of U.S. infrastructure projects, says Thibaut Giret at Alstef Group.

  • Series

    Bass Fishing Makes Me A Better Lawyer

    Author Photo

    Landing a trophy striped bass and closing a big deal both require cultivating the patience to finesse — not force — your way to desired outcomes, changing course when your old approach isn’t working and learning from the ones that got away, says Jon Ruiss at Alston & Bird.

  • What Consent Decree Trends Mean For Deal Clearances

    Author Photo

    With merger remedies back on the table under the current administration, an analysis of recent Federal Trade Commission and U.S. Department of Justice consent decrees reveals that prior approval and prior notice provisions are no longer a foregone conclusion, and companies may be able to negotiate narrowly tailored obligations, say attorneys at Weil.

  • How Reincorporating In Texas May Alter Earnout Disputes

    Author Photo

    While the DExit debate has focused on shareholder suits, far less attention has been paid to what reincorporating in Texas means for M&A disputes, making it particularly important to understand the nuances between Delaware and Texas earnout jurisprudence, say attorneys at Selendy Gay.

  • Roundup

    The Most Talked-About Supreme Court Decisions Of 2026

    Author Photo

    This term, 11 U.S. Supreme Court decisions quickly became hot topics among Law360's guest writers.

  • Structuring Space Nuclear Deals For Regulatory Risk

    Author Photo

    With the White House's recent focus on space nuclear power, a highly important question for companies that want to build orbital reactors, lunar surface systems or critical components is whether the transaction documents can handle foreign investment constraints, export controls and treaty-linked liability, says Kristie Blase at Frazer + Blase.

  • Texas Business Court Rulings Show Deal Terms Paramount

    Author Photo

    As the courts within the Texas Business Court system have begun reaching the substantive merits of the cases before them, they are persuasively demonstrating they will not only enforce the terms of transactions as written, but will also embrace a holistic approach to complex transaction documentation interpretation, says Christopher Pace at Winston Taylor.

  • Quantum Readiness May Paradoxically Raise Contractor Risk

    Author Photo

    The organizations best positioned for the cryptographic system migration deadlines and other requirements under President Donald Trump’s recent quantum executive orders will be those able to inventory their cryptographic dependencies while protecting their vulnerability road map from adversaries, says Jesse Lemon at The Beckage Firm.

  • Why Biotech Cos. Need Litigation Plans Before Bad News

    Author Photo

    Biotech companies should take proactive steps to respond to the growing trend of securities litigation filed against them, due to the inherently uncertain nature of their business models and heightened scrutiny of clinical trial disclosures, regulatory communications and investor-facing statements, says Wesley Horton at FBFK.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Mergers & Acquisitions archive.